Next, we detected the AIM2 expression in BRAF inhibitor PLX8394-treated BRAF-mutant CRC cells, we found that BRAF inhibitor administration enhanced AIM2 expression, indicating that BRAF inhibition could restore AIM2 expression in CRC cell lines (Supplementary Figure 1). Here, AIM2 is linked to colorectal carcinoma.